Bad dilution, circa 250M shares on issue post raise, assuming the 30c options will also be executed. $500M takeover required to match Sumi's $2 offer from 2019.
The good to come of this CR:
1. When this cash runs out, we will have clinical trial results from DFU, GvHD and Renal trials.
2. Maybe the gag on brokers by SI is over?
Ann: Trading Halt, page-8
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.010(4.00%) |
Mkt cap ! $46.70M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 26.5¢ | 24.5¢ | $22.36K | 88.15K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 4125 | 2 |
View Market Depth
| Last trade - 15.55pm 10/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |